Microbial transmission from mothers with obesity or diabetes to infants: an innovative opportunity to interrupt a vicious cycle

Diabetologia

Volumn 59, Issue 5, 2016, Pages 895-906

  Soderborg, Taylor K ^a   Borengasser, Sarah J ^a   Barbour, Linda A ^b   Friedman, Jacob E ^a,b  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Infant; Maternal; Microbiome; Obesity; Pregnancy; Review

Indexed keywords

ANTIBIOTIC AGENT; BILE ACID; PREBIOTIC AGENT; PROBIOTIC AGENT;

BREAST FEEDING; CHILDHOOD OBESITY; DELIVERY; DRUG EXPOSURE; EPIGENETICS; FEMALE; HUMAN; IMMUNITY; INFANT; MATERNAL DIABETES MELLITUS; MATERNAL NUTRITION; MATERNAL OBESITY; METABOLIC DISORDER; METABOLISM; MICROBIAL COLONIZATION; MICROBIAL COMMUNITY; MICROBIOME; MICROFLORA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; VERTICAL TRANSMISSION; ANIMAL; MICROBIOLOGY; MOTHER; NEWBORN; OBESITY; PHYSIOLOGY;

ANIMALS; FEMALE; HUMANS; INFANT, NEWBORN; MICROBIOTA; MOTHERS; OBESITY; PREGNANCY;

EID: 84957539808     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-016-3880-0     Document Type: Review

References (99)

1. Heerwagen MJ, Miller MR, Barbour LA, Friedman JE (2010) Maternal obesity and fetal metabolic programming: a fertile epigenetic soil. Am J Physiol Regul Integr Comp Physiol 299:R711–R722
2. Nolan CJ (2013) Normal long-term health for infants of diabetic mothers: can we achieve it? J Clin Endocrinol Metab 98:3592–3594
3. Friedman JE (2015) Obesity and gestational diabetes mellitus pathways for programming in mouse, monkey, and man—where do we go next? The 2014 Norbert Freinkel Award Lecture. Diabetes Care 38:1402–1411
4. Barbour LA (2014) Changing perspectives in pre-existing diabetes and obesity in pregnancy: maternal and infant short- and long-term outcomes. Curr Opin Endocrinol Diabetes Obes 21:257–263
5. Weng SF, Redsell SA, Nathan D, Swift JA, Yang M, Glazebrook C (2013) Estimating overweight risk in childhood from predictors during infancy. Pediatrics 132:e414–e421
6. Boney CM, Verma A, Tucker R, Vohr BR (2005) Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 115:e290–e296
7. McCurdy CE, Bishop JM, Williams SM et al (2009) Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. J Clin Invest 119:323–335
8. Thorn SR, Baquero KC, Newsom SA et al (2014) Early life exposure to maternal insulin resistance has persistent effects on hepatic NAFLD in juvenile nonhuman primates. Diabetes 63:2702–2713
9. Brumbaugh DE, Tearse P, Cree-Green M et al (2013) Intrahepatic fat is increased in the neonatal offspring of obese women with gestational diabetes. J Pediatr 162:930–936
10. Brumbaugh DE, Friedman JE (2014) Developmental origins of nonalcoholic fatty liver disease. Pediatr Res 75:140–147
11. Sullivan EL, Nousen EK, Chamlou KA, Grove KL (2012) The impact of maternal high-fat diet consumption on neural development and behavior of offspring. Int J Obes Suppl 2:S7–S13
12. Boyle KE, Patinkin ZW, Shapiro ALB, Baker PR II, Dabelea D, Friedman JE (2015) Mesenchymal stem cells from infants born to obese mothers exhibit greater potential for adipogenesis: the Healthy Start BabyBUMP Project. Diabetes. doi:10.2337/db15-0849
13. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:1027–1031
14. Ridaura VK, Faith JJ, Rey FE et al (2013) Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341:1241214
15. Koleva PT, Bridgman SL, Kozyrskyj AL (2015) The infant gut microbiome: evidence for obesity risk and dietary intervention. Nutrients 7:2237–2260
16. Ma J, Prince AL, Bader D et al (2014) High-fat maternal diet during pregnancy persistently alters the offspring microbiome in a primate model. Nat Commun 5:3889
17. Mirpuri J, Raetz M, Sturge CR et al (2014) Proteobacteria-specific IgA regulates maturation of the intestinal microbiota. Gut Microbes 5:28–39
18. Eggesbø M, Moen B, Peddada S et al (2011) Development of gut microbiota in infants not exposed to medical interventions. APMIS 119:17–35
19. Koenig JE, Spor A, Scalfone N et al (2011) Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A 108:4578–4585
20. Bäckhed F, Roswall J, Peng Y et al (2015) Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17:690–703
21. Santacruz A, Collado MC, García-Valdés L et al (2010) Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J Nutr 104:83–92
22. Collado MC, Isolauri E, Laitinen K, Salminen S (2008) Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr 88:894–899
23. Basu S, Haghiac M, Surace P et al (2011) Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity 19:476–482
24. Koren O, Goodrich JK, Cullender TC et al (2012) Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 150:470–480
25. DiGiulio DB, Callahan BJ, McMurdie PJ et al (2015) Temporal and spatial variation of the human microbiota during pregnancy. Proc Natl Acad Sci U S A 112:11060–11065
26. Dominguez-Bello MG, Costello EK, Contreras M et al (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 107:11971–11975
27. Dogra S, Sakwinska O, Soh SE et al (2015) Dynamics of infant gut microbiota are influenced by delivery mode and gestational duration and are associated with subsequent adiposity. MBio 6, e02419
28. Azad MB, Konya T, Maughan H et al (2013) Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. CMAJ 185:385–394
29. Mueller NT, Whyatt R, Hoepner L et al (2015) Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity. Int J Obes (Lond) 39:665–670
30. Cardwell CR, Stene LC, Joner G et al (2008) Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia 51:726–735
31. Hu J, Nomura Y, Bashir A et al (2013) Diversified microbiota of meconium is affected by maternal diabetes status. PLoS One 8, e78257
32. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J (2014) The placenta harbors a unique microbiome. Sci Transl Med 6:237ra265
33. Savino F, Benetti S, Liguori SA, Sorrenti M, Cordero Di Montezemolo L (2013) Advances on human milk hormones and protection against obesity. Cell Mol Biol 59:89–98
34. Yan J, Liu L, Zhu Y, Huang G, Wang PP (2014) The association between breastfeeding and childhood obesity: a meta-analysis. BMC Public Health 14:1267
35. Young BE, Johnson SL, Krebs NF (2012) Biological determinants linking infant weight gain and child obesity: current knowledge and future directions. Adv Nutr 3:675–686
36. Woo JG, Martin LJ (2015) Does breastfeeding protect against childhood obesity? Moving beyond observational evidence. Curr Obes Rep 4:207–216
37. Oben JA, Mouralidarane A, Samuelsson AM et al (2010) Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice. J Hepatol 52:913–920
38. Myles IA, Fontecilla NM, Janelsins BM, Vithayathil PJ, Segre JA, Datta SK (2013) Parental dietary fat intake alters offspring microbiome and immunity. J Immunol 191:3200–3209
39. Zivkovic AM, German JB, Lebrilla CB, Mills DA (2011) Human milk glycobiome and its impact on the infant gastrointestinal microbiota. Proc Natl Acad Sci U S A 108:4653–4658
40. Bode L (2009) Human milk oligosaccharides: prebiotics and beyond. Nutr Rev 67:S183–S191
41. Wacklin P, Mäkivuokko H, Alakulppi N et al (2011) Secretor genotype (FUT2 gene) is strongly associated with the composition of Bifidobacteria in the human intestine. PLoS One 6, e20113
42. Martin R, Jimenez E, Heilig H et al (2009) Isolation of bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-denaturing gradient gel electrophoresis and quantitative real-time PCR. Appl Environ Microbiol 75:965–969
43. Hunt KM, Foster JA, Forney LJ et al (2011) Characterization of the diversity and temporal stability of bacterial communities in human milk. PLoS One 6, e21313
44. Cabrera-Rubio R, Collado MC, Laitinen K, Salminen S, Isolauri E, Mira A (2012) The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr 96:544–551
45. Young BE, Morrow A, Davidson B, Geraghty S, Patinkin ZW, Krebs NF (2014) 4-Hydroxynonenol is present in human milk and related to gestational age at delivery and excessive infant weight gain. FASEB J 28:247.246
46. Fields DA, Demerath EW (2012) Relationship of insulin, glucose, leptin, IL-6 and TNF-alpha in human breast milk with infant growth and body composition. Pediatr Obes 7:304–312
47. Thormar H, Isaacs CE, Brown HR, Barshatzky MR, Pessolano T (1987) Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides. Antimicrob Agents Chemother 31:27–31
48. Matias SL, Dewey KG, Quesenberry CP Jr, Gunderson EP (2014) Maternal prepregnancy obesity and insulin treatment during pregnancy are independently associated with delayed lactogenesis in women with recent gestational diabetes mellitus. Am J Clin Nutr 99:115–121
49. Stuebe AM (2015) Does breastfeeding prevent the metabolic syndrome, or does the metabolic syndrome prevent breastfeeding? Semin Perinatol 39:290–295
50. Roger LC, Costabile A, Holland DT, Hoyles L, McCartney AL (2010) Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life. Microbiology 156:3329–3341
51. Bailey LC, Forrest CB, Zhang P, Richards TM, Livshits A, DeRusso PA (2014) Association of antibiotics in infancy with early childhood obesity. JAMA Pediatr 168:1063–1069
52. Azad MB, Bridgman SL, Becker AB, Kozyrskyj AL (2014) Infant antibiotic exposure and the development of childhood overweight and central adiposity. Int J Obes (Lond) 38:1290–1298
53. Cho I, Yamanishi S, Cox L et al (2012) Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488:621–626
54. Cox LM, Yamanishi S, Sohn J et al (2014) Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158:705–721
55. Nobel YR, Cox LM, Kirigin FF et al (2015) Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment. Nat Commun 6:7486
56. Ajslev TA, Andersen CS, Gamborg M, Sorensen TI, Jess T (2011) Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics. Int J Obes (Lond) 35:522–529
57. Trasande L, Blustein J, Liu M, Corwin E, Cox LM, Blaser MJ (2013) Infant antibiotic exposures and early-life body mass. Int J Obes (Lond) 37:16–23
58. Maynard CL, Elson CO, Hatton RD, Weaver CT (2012) Reciprocal interactions of the intestinal microbiota and immune system. Nature 489:231–241
59. DeSisto CL, Kim SY, Sharma AJ (2014) Prevalence estimates of gestational diabetes mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007–2010. Prev Chronic Dis 11, E104
60. Buckley BS, Harreiter J, Damm P et al (2012) Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review. Diabet Med 29:844–854
61. Larsen N, Vogensen FK, van den Berg FW et al (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5, e9085
62. Fugmann M, Breier M, Rottenkolber M et al (2015) The stool microbiota of insulin resistant women with recent gestational diabetes, a high risk group for type 2 diabetes. Sci Rep 5:13212
63. Wright DP, Rosendale DI, Robertson AM (2000) Prevotella enzymes involved in mucin oligosaccharide degradation and evidence for a small operon of genes expressed during growth on mucin. FEMS Microbiol Lett 190:73–79
64. Fahrenkrog S, Harder T, Stolaczyk E et al (2004) Cross-fostering to diabetic rat dams affects early development of mediobasal hypothalamic nuclei regulating food intake, body weight, and metabolism. J Nutr 134:648–654
65. Priyadarshini M, Thomas A, Reisetter AC et al (2014) Maternal short-chain fatty acids are associated with metabolic parameters in mothers and newborns. Transl Res 164:153–157
66. Park J, Kim M, Kang SG et al (2015) Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol 8:80–93
67. Jumpertz R, Le DS, Turnbaugh PJ et al (2011) Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr 94:58–65
68. Chang PV, Hao L, Offermanns S, Medzhitov R (2014) The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A 111:2247–2252
69. Schwiertz A, Taras D, Schäfer K et al (2010) Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 18:190–195
70. Bellahcene M, O’Dowd JF, Wargent ET et al (2013) Male mice that lack the G-protein-coupled receptor GPR41 have low energy expenditure and increased body fat content. Br J Nutr 109:1755–1764
71. den Besten G, Bleeker A, Gerding A et al (2015) Short-chain fatty acids protect against high-fat diet-induced obesity via a PPARγ-dependent switch from lipogenesis to fat oxidation. Diabetes 64:2398–2408
72. Li HP, Chen X, Li MQ (2013) Butyrate alleviates metabolic impairments and protects pancreatic beta cell function in pregnant mice with obesity. Int J Clin Exp Pathol 6:1574–1584
73. Ohira H, Fujioka Y, Katagiri C et al (2013) Butyrate attenuates inflammation and lipolysis generated by the interaction of adipocytes and macrophages. J Atheroscler Thromb 20:425–442
74. Macia L, Tan J, Vieira AT et al (2015) Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat Commun 6:6734
75. Voltolini C, Battersby S, Etherington SL, Petraglia F, Norman JE, Jabbour HN (2012) A novel antiinflammatory role for the short-chain fatty acids in human labor. Endocrinology 153:395–403
76. Takahashi K (2014) Influence of bacteria on epigenetic gene control. Cell Mol Life Sci 71:1045–1054
77. Sealy L, Chalkley R (1978) The effect of sodium butyrate on histone modification. Cell 14:115–121
78. Furusawa Y, Obata Y, Fukuda S et al (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504:446–450
79. Arpaia N, Campbell C, Fan X et al (2013) Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation. Nature 504:451–455
80. Kellermayer R, Dowd SE, Harris RA et al (2011) Colonic mucosal DNA methylation, immune response, and microbiome patterns in Toll-like receptor 2-knockout mice. FASEB J 25:1449–1460
81. Kumar H, Lund R, Laiho A et al (2014) Gut microbiota as an epigenetic regulator: pilot study based on whole-genome methylation analysis. MBio 5, e02113
82. Hofmann AF, Hagey LR (2008) Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cell Mol Life Sci 65:2461–2483
83. Trabelsi MS, Daoudi M, Prawitt J et al (2015) Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells. Nat Commun 6:7629
84. Selwyn FP, Csanaky IL, Zhang Y, Klaassen CD (2015) Importance of large intestine in regulating bile acids and glucagon-like peptide-1 in germ-free mice. Drug Metab Dispos 43:1544–1556
85. McMahan RH, Wang XX, Cheng LL et al (2013) Bile acid receptor activation modulates hepatic monocyte activity and improves nonalcoholic fatty liver disease. J Biol Chem 288:11761–11770
86. Wang YD, Chen WD, Yu D, Forman BM, Huang W (2011) The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-kappaB) in mice. Hepatology 54:1421–1432
87. Gadaleta RM, van Erpecum KJ, Oldenburg B et al (2011) Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease. Gut 60:463–472
88. Islam KB, Fukiya S, Hagio M et al (2011) Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology 141:1773–1781
89. Everard A, Lazarevic V, Derrien M et al (2011) Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60:2775–2786
90. Lindsay KL, Brennan L, Kennelly MA et al (2015) Impact of probiotics in women with gestational diabetes mellitus on metabolic health: a randomized controlled trial. Am J Obstet Gynecol 212:496.e491-411
91. Maurer AD, Eller LK, Hallam MC, Taylor K, Reimer RA (2010) Consumption of diets high in prebiotic fiber or protein during growth influences the response to a high fat and sucrose diet in adulthood in rats. Nutr Metab (Lond) 7:77
92. Rautava S, Collado MC, Salminen S, Isolauri E (2012) Probiotics modulate host-microbe interaction in the placenta and fetal gut: a randomized, double-blind, placebo-controlled trial. Neonatology 102:178–184
93. Luoto R, Laitinen K, Nermes M, Isolauri E (2010) Impact of maternal probiotic-supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: a double-blind, placebo-controlled study. Br J Nutr 103:1792–1799
94. Ilmonen J, Isolauri E, Poussa T, Laitinen K (2011) Impact of dietary counselling and probiotic intervention on maternal anthropometric measurements during and after pregnancy: a randomized placebo-controlled trial. Clin Nutr 30:156–164
95. Lindsay KL, Kennelly M, Culliton M et al (2014) Probiotics in obese pregnancy do not reduce maternal fasting glucose: a double-blind, placebo-controlled, randomized trial (Probiotics in Pregnancy Study). Am J Clin Nutr 99:1432–1439
96. Laitinen K, Poussa T, Isolauri E (2009) Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial. Br J Nutr 101:1679–1687
97. Schultz M, Gottl C, Young RJ, Iwen P, Vanderhoof JA (2004) Administration of oral probiotic bacteria to pregnant women causes temporary infantile colonization. J Pediatr Gastroenterol Nutr 38:293–297
98. Gueimonde M, Sakata S, Kalliomäki M, Isolauri E, Benno Y, Salminen S (2006) Effect of maternal consumption of Lactobacillus GG on transfer and establishment of fecal bifidobacterial microbiota in neonates. J Pediatr Gastroenterol Nutr 42:166–170
99. Ismail IH, Oppedisano F, Joseph SJ, Boyle RJ, Robins-Browne RM, Tang ML (2012) Prenatal administration of Lactobacillus rhamnosus has no effect on the diversity of the early infant gut microbiota. Pediatr Allergy Immunol 23:255–258